Dendritic cells transfected with PD-L1 recombinant adenovirus induces T cell suppression and long-term acceptance of allograft transplantation

Cellular Immunology

Volumn 271, Issue 1, 2011, Pages 73-77

  Peng, Wei ^a   Ran, Boli ^b   Ma, Yuanzheng ^a   Huang, Xunwu ^a   Chang, Qing ^a   Wang, Xiangwei ^b  

^a 309TH HOSPITAL OF PLA   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus; Allograft transplantation; Dendritic cells; PD L1

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BIOLOGICAL MARKER; CD69 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PROGRAMMED DEATH 1 LIGAND 1;

ADENOVIRUS; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL STRAIN HEK293; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GENETIC TRANSFECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD274; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; HEK293 CELLS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; PROTEINURIA; RATS; RATS, INBRED F344; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TIME FACTORS; TRANSFECTION; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

ADENOVIRIDAE; RATTUS;

EID: 80052381463     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.06.007     Document Type: Article

References (35)

1. Kitamura N., Murata S., Ueki T., Mekata E., Reilly R.T., Jaffee E.M., Tani T. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity. Int. J. Cancer 2009, 125(3):630-638.
2. Altvater B., Landmeier S., Pscherer S., Temme J., Juergens H., Pule M., Rossig C. 2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells. Cancer Immunol. Immunother. 2009, 58(12):1991-2001.
3. Mostbock S., Vidal S., Schlom J., Sabzevari H. Enhanced levels of costimulation lead to reduced effector/memory CD8+ T cell functionality. J. Immunol. 2007, 179(6):3524-3534.
4. Mangada J., Pearson T., Brehm M.A., Wicker L.S., Peterson L.B., Shultz L.D., Serreze D.V., Rossini A.A., Greiner D.L. Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice. Diabetes 2009, 58(1):165-173.
5. Vincenti F. Costimulation blockade in autoimmunity and transplantation. J. Allergy Clin. Immunol. 2008, 121(2):299-306.
6. Hussain S., Delovitch T.L. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. J. Immunol. 2005, 174(2):680-687.
7. Wong R.M., Smith K.A., Tam V.L., Pagarigan R.R., Meisenburg B.L., Quach A.M., Carrillo M.A., Qiu Z., Bot A.I. TLR-9 signaling and TCR stimulation co-regulate CD8(+) T cell-associated PD-1 expression. Immunol. Lett. 2009, 127(1):60-67.
8. Grosso J.F., Goldberg M.V., Getnet D., Bruno T.C., Yen H.R., Pyle K.J., Hipkiss E., Vignali D.A., Pardoll D.M., Drake C.G. Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. J. Immunol. 2009, 182(11):6659-6669.
9. Plege A., Borns K., Baars W., Schwinzer R. Suppression of human T-cell activation and expansion of regulatory T cells by pig cells overexpressing PD-ligands. Transplantation 2009, 87(7):975-982.
10. Shvets A., Chakrabarti R., Gonzalez-Quintial R., Baccala R., Theofilopoulos A.N., Prud'homme G.J. Impaired negative regulation of homeostatically proliferating T cells. Blood 2009, 113(3):622-625.
11. Lucas J.A., Menke J., Rabacal W.A., Schoen F.J., Sharpe A.H., Kelley V.R. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice. J. Immunol. 2008, 181(4):2513-2521.
12. Haspot F., Fehr T., Gibbons C., Zhao G., Hogan T., Honjo T., Freeman G.J., Sykes M. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. Blood 2008, 112(5):2149-2155.
13. Kitazawa Y., Fujino M., Wang Q., Kimura H., Azuma M., Kubo M., Abe R., Li X.K. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Transplantation 2007, 83(6):774-782.
14. Proietto A.I., van Dommelen S., Zhou P., Rizzitelli A., D'Amico A., Steptoe R.J., Naik S.H., Lahoud M.H., Liu Y., Zheng P., Shortman K., Wu L. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(50):19869-19874.
15. Akbari O., Umetsu D.T. Role of regulatory dendritic cells in allergy and asthma. Curr. Allergy Asthma Rep. 2005, 5(1):56-61.
16. Grohmann U., Bianchi R., Orabona C., Fallarino F., Vacca C., Micheletti A., Fioretti M.C., Puccetti P. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J. Immunol. 2003, 171(5):2581-2587.
17. Terness P., Bauer T.M., Rose L., Dufter C., Watzlik A., Simon H., et al. 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 2002, 196(4):447-457.
18. Min W.P., Gorczynski R., Huang X.Y., Kushida M., Kim P., Obataki M., et al. J. Immunol. 2000, 164(1):161-167.
19. Lu L., Gambotto A., Lee W.C., Qian S., Bonham C.A., Robbins P.D., et al. Gene Ther. 1999, 6(4):554-563.
20. Takayama T., Nishioka Y., Lu L., Lotze M.T., Tahara H., Thomson A.W. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 1998, 66(12):1567-1574.
21. Millan O., Urtasun N., Brunet M. Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients. Transplant Rev (Orlando) 2009, 23(2):120-128.
22. Demirkiran A., Hendrikx T.K., Baan C.C., van der Laan L.J. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?. Transplantation 2008, 85(6):783-789.
23. Mathew J.M., Carreno M., Zucker K., Fuller L., Kenyon N., Esquenazi V., Ricordi C., Tzakis A.G., Miller J. Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation. Transplantation 1998, 65(7):947-955.
24. Li Z., Benghiat F.S., Charbonnier L.M., Kubjak C., Rivas M.N., Cobbold S.P., et al. CD8+ T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in mice. Am. J. Transplant. 2008, 8(12):2527-2536.
25. Fehr T., Wang S., Haspot F., Kurtz J., Blaha P., Hogan T., et al. J. Immunol. 2008, 181(6):4371-4380.
26. Fehr T., Haspot F., Mollov J., Chittenden M., Hogan T., Sykes M. Alloreactive CD8 T cell tolerance requires recipient B cells dendritic cells and MHC class II. J. Immunol. 2008, 181(1):165-173.
27. Yoshida A., Narumi S., Hashimoto N., Itabashi Y., Hakamada K., Sasaki M. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice. Transplant. Proc. 2004, 36(8):2418-2422.
28. Matsumoto A., Dobashi H., Ohnishi H., et al. Microbiol. Immunol. 2003, 47(1):63-69.
29. Vasilevko V., Ghochikyan A., Holterman M.J., et al. DNA Cell Biol. 2002, 21(3):137-149.
30. Graca L. CTLA4Ig and the therapeutic potential of T cell co-stimulation blockade. Acta reumatologica portuguesa 2008, 33(3):267-276.
31. Gao Y., Whitaker-Dowling P., Griffin J.A., Barmada M.A., Bergman I. Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors. Cancer Gene Ther. Jan 2009, 16(1):44-52.
32. Zhu P., Chen Y.F., Chen X.P., Li D., Cheng Q., Huang Z.Y., et al. Transplant. Proc. Jun 2008, 40(5):1618-1624.
33. Tokita D., Mazariegos G.V., Zahorchak A.F., Chien N., Abe M., Raimondi G., et al. Transplantation 2008, 85(3):369-377.
34. Ohnmacht C., Pullner A., King S.B., Drexler I., Meier S., Brocker T., et al. J. Exp. Med. 2009, 206(3):549-559.
35. Villadangos J.A., Schnorrer P. Intrinsic cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. 2007, 7(7):543-555.